SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
SNIPR Biome has raised $40.8M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
SNIPR Biome's investors include Bill & Melinda Gates Foundation, CARB-X, EQT Life Sciences, Wellington Partners, Cystic Fibrosis Foundation.
SNIPR Biome is headquartered in Copenhagen, Denmark.
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
SNIPR Biome is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SNIPR Biome — Funding & Investors." VCBacked, August 7, 2025, https://www.vcbacked.co/company/snipr-biome. Accessed July 19, 2026.
VCBacked. (2025). SNIPR Biome — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/snipr-biome
{{cite web |title=SNIPR Biome — Funding & Investors |url=https://www.vcbacked.co/company/snipr-biome |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated